188 related articles for article (PubMed ID: 10770996)
1. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically.
Reuben M; Boye S; Clarke PB
Eur J Pharmacol; 2000 Mar; 393(1-3):39-49. PubMed ID: 10770996
[TBL] [Abstract][Full Text] [Related]
2. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.
Reuben M; Clarke PB
Neuropharmacology; 2000 Jan; 39(2):290-9. PubMed ID: 10670424
[TBL] [Abstract][Full Text] [Related]
4. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release.
Grilli M; Parodi M; Raiteri M; Marchi M
J Neurochem; 2005 Jun; 93(5):1353-60. PubMed ID: 15934954
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
6. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
[TBL] [Abstract][Full Text] [Related]
7. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
Reuben M; Louis M; Clarke PB
Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
[TBL] [Abstract][Full Text] [Related]
8. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
9. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
Dwoskin LP; Teng L; Buxton ST; Crooks PA
J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
Sacaan AI; Dunlop JL; Lloyd GK
J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
[TBL] [Abstract][Full Text] [Related]
11. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
12. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
Azam L; McIntosh JM
Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
[TBL] [Abstract][Full Text] [Related]
13. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.
Sershen H; Balla A; Lajtha A; Vizi ES
Neuroscience; 1997 Mar; 77(1):121-30. PubMed ID: 9044380
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.
Wilkie GI; Hutson P; Sullivan JP; Wonnacott S
Neurochem Res; 1996 Sep; 21(9):1141-8. PubMed ID: 8897478
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum.
Wonnacott S; Kaiser S; Mogg A; Soliakov L; Jones IW
Eur J Pharmacol; 2000 Mar; 393(1-3):51-8. PubMed ID: 10770997
[TBL] [Abstract][Full Text] [Related]
17. Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture.
Gallardo KA; Leslie FM
J Neurochem; 1998 Feb; 70(2):663-70. PubMed ID: 9453560
[TBL] [Abstract][Full Text] [Related]
18. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Sidhpura N; Redfern P; Wonnacott S
Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
[TBL] [Abstract][Full Text] [Related]
20. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.
Miller DK; Crooks PA; Dwoskin LP
Neuropharmacology; 2000 Oct; 39(13):2654-62. PubMed ID: 11044735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
